CancerNetwork
Tarik Hadid, M.D., MPH, MS, FACP, medical oncologist and member of the Phase I Clinical Trials and Thoracic Oncology Multidisciplinary Teams at Karmanos, joined the CancerNetwork Satellite Sessions program to discuss the best first-line treatment options for non-small cell lung cancer. The group of oncologists discussed MARIPOSA trials and findings, FLAURA and FLAURA2, helping patients decide on a treatment, how metastasis factors into treatment, and ctDNA analysis and additional testing.
Read the discussion here.